Cerevel Therapeutics (NASDAQ:CERE) Downgraded to Neutral at Cantor Fitzgerald
Cantor Fitzgerald cut shares of Cerevel Therapeutics (NASDAQ:CERE – Free Report) from an overweight rating to a neutral rating in a report issued on Thursday, MarketBeat reports. Cantor Fitzgerald currently has $45.00 price objective on the biotechnology company’s stock, up from their previous price objective of $38.00. A number of other brokerages have also recently […]
More Stories
Ripe for the Picking Season 2: Release Date, Cast, and More
Ripe for the Picking is a Japanese manga series. It was first released as a magazine before becoming a web...
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...
Let’s Talk About Chu Season 2: Release Date, Cast, and More
The romantic-comedy Taiwanese series Let’s Talk About Chu has become one of the most talked-about series since its release in...
Office Romance is Released! Watch Jennifer Lopez and Brett Goldstein’s Exotic Romance
Looking for a romantic-comedy film to watch with your partner or loved ones this weekend? Jennifer Lopez’s recent film, Office...
The Quiet Logistics Shift Changing How Shoppers Collect Fresh Food
Nobody talks about this, but it’s happening everywhere. The way grocery stores handle order collection is changing. Not in a...
Why Offices Sound Worse Than Ever, And the Engineering Fix Hiding in Plain Sight
Open-plan offices were meant to feel modern, bright, and collaborative. In reality, many feel like a mix of café, hallway,...